Trials / Completed

CompletedNCT00192244

Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live, Cold-Adapted (CAIV-T) in Healthy Children

A Prospective, Randomized, Double-Blind, Placebo-Controlled, Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) in Healthy Children

Status: Completed
Phase: Phase 3
Study type: Interventional
Enrollment: 3,000 (planned)

Sponsor: MedImmune LLC · Industry
Sex: All
Age: 6 Months – 35 Months
Healthy volunteers: Accepted

Summary

\- The purpose of this study is to determine the efficacy of CAIV-T in a diverse Asian population aged from 6 months to less than 36 months, in tropical and temperate climates, against culture-confirmed influenza illness. In addition, the trial provides the opportunity to investigate the efficacy of CAIV-T over multiple influenza seasons, and to investigate the effect of CAIV-T on acute otitis media.

Conditions

Healthy

Interventions

Type	Name	Description
BIOLOGICAL	CAIV-T, Liquid

Timeline

Start date: 2000-09-01
Completion: 2002-10-01
First posted: 2005-09-19
Last updated: 2006-10-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT00192244. Inclusion in this directory is not an endorsement.